Cognitive behaviour therapy in medication-treated adults with ADHD and persistent Symptoms: A randomized controlled trial

被引：123

作者：

Emilsson, Brynjar ^{[1
,2
]}

Gudjonsson, Gisli ^{[1
]}

Sigurdsson, Jon F. ^{[2
]}

Baldursson, Gisli ^{[2
]}

Einarsson, Emil ^{[2
]}

Olafsdottir, Halldora ^{[2
]}

Young, Susan ^{[1
]}

机构：

[1] Kings Coll London, Inst Psychiat, London WC2R 2LS, England

[2] Landspitali Natl Univ Hosp Iceland, Reykjavik, Iceland

来源：

BMC PSYCHIATRY | 2011年 / 11卷

关键词：

REHABILITATION PROGRAM; HYPERACTIVITY; PREVALENCE; COMORBIDITY;

D O I：

10.1186/1471-244X-11-116

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

Background: Attention deficit hyperactivity disorder (ADHD) in adulthood is not fully treated by psychopharmacological treatment alone. The main aim of the current study was to evaluate a newly developed cognitive behaviour therapy (CBT) based group programme, the Reasoning and Rehabilitation for ADHD Youths and Adults (R&R2ADHD), using a randomized controlled trial. Methods: 54 adults with ADHD already receiving psychopharmacological treatment were randomly allocated to an experimental (CBT/MED) treatment condition (n = 27) and a 'treatment as usual' (TAU/MED) control condition (n = 27) that did not receive the CBT intervention. The outcome measures were obtained before treatment (baseline), after treatment and at three month follow-up and included ADHD symptoms and impairments rated by independent assessors, self-reported current ADHD symptoms, and comorbid problems. Results: The findings suggested medium to large treatment effects for ADHD symptoms, which increased further at three month follow-up. Additionally, comorbid problems also improved at follow-up with large effect sizes. Conclusions: The findings give support for the effectiveness of R&R2ADHD in reducing ADHD symptoms and comorbid problems, an improving functions associated with impairment. The implications are that the benefits of R&R2ADHD are multifaceted and that combined psychopharmacological and CBT based treatments may add to and improve pharmacological interventions.

引用

页数：10